Melatonin Should Not Be Routinely Used in Infants Under 1 Year of Age
Melatonin is not recommended for infants younger than 12 months due to lack of safety and efficacy data in this age group, with existing guidelines only addressing children 6 years and older.
Evidence-Based Rationale
Guideline Recommendations
The American Academy of Sleep Medicine (AASM) 2015 clinical practice guideline for circadian rhythm sleep-wake disorders provides dosing recommendations only for children aged 6-12 years and older 1. The guideline explicitly studied:
- Children 6-12 years: 0.05-0.15 mg/kg doses
- Optimal dose: 0.15 mg/kg taken 1.5-2 hours before bedtime
- No data or recommendations exist for infants under 1 year
Critical Safety Gaps
The AASM guideline acknowledges that "relevant concerns have been raised by select studies with respect to the pediatric/adolescent population, and rigorous long-term data are lacking" 1. This uncertainty is magnified in infants where:
- No controlled trials exist for infants <12 months with typical development
- Long-term developmental effects are unknown during critical brain maturation periods
- The benefits/harms assessment remains uncertain even in older children
Limited Research Data in Infants
While one retrospective study examined melatonin use in 55 infants admitted to intensive care units (median age 5.5 months), this involved a highly specialized population with critical illness, not healthy infants 2. The median dose was 0.31 mg/kg/dose, but this cannot be extrapolated to routine use in healthy infants.
Pharmacokinetic studies in preterm neonates show dramatically different metabolism compared to older children and adults, with half-lives of 8-11 hours (much longer than adults) 3. This suggests unpredictable drug accumulation risk in young infants.
Clinical Approach for Infant Sleep Problems
Instead of melatonin, address the underlying cause:
- Behavioral interventions first: Age-appropriate sleep schedules, consistent bedtime routines, sleep environment optimization
- Rule out medical causes: Reflux, pain, feeding issues, respiratory problems
- Parental education: Normal infant sleep patterns, safe sleep practices
- Consider referral to pediatric sleep specialist if persistent concerns
Important Caveats
- Recent systematic reviews highlight rising melatonin overdoses in young children (0-6 years), now the leading cause of unsupervised medication exposure in emergency departments 4
- The 2025 IPSA consensus recommendations for typically developing children do not support routine use in infants 5
- Melatonin remains unregulated as a dietary supplement with variable product quality and actual dosing 6
If melatonin is being considered for an infant with severe neurological conditions or in specialized settings (e.g., neonatal encephalopathy trials), this should only occur under direct supervision of pediatric specialists with appropriate monitoring protocols 7.